Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-23 LOEB GARY EVP, General Counsel & Sec. Exercise or conversion +11,981 $11.02 $132K 100,762
2021-03-23 LOEB GARY EVP, General Counsel & Sec. Sale −11,981 $13.10 $157K 88,781
2021-03-23 LOEB GARY EVP, General Counsel & Sec. Sale −5,000 $13.18 $66K 83,781
2021-03-23 LOEB GARY EVP, General Counsel & Sec. Sale −543 $13.17 $7K 83,238
2021-03-23 LOEB GARY EVP, General Counsel & Sec. Exercise or conversion · Stock Option (Right-to-Buy) −11,981 238,019
2021-02-25 Duraibabu Prathyusha VP, PFO and PAO Shares withheld for taxes −1,863 $11.19 $21K 27,385
2021-02-25 Duraibabu Prathyusha VP, PFO and PAO Grant or award +13,750 41,135
2021-02-25 Duraibabu Prathyusha VP, PFO and PAO Grant or award · Stock Option (Right to Buy) +27,500 27,500
2021-02-25 Duraibabu Prathyusha VP Principal Acct. Officer Shares withheld for taxes −1,863 $11.19 $21K 27,385
2021-02-25 Duraibabu Prathyusha VP Principal Acct. Officer Grant or award +13,750 41,135
2021-02-25 Duraibabu Prathyusha VP Principal Acct. Officer Grant or award · Stock Option (Right to Buy) +27,500 27,500
2021-02-25 Ramelmeier Rolf Andrew EVP, Technical Operations Shares withheld for taxes −7,779 $11.19 $87K 58,199
2021-02-25 Ramelmeier Rolf Andrew EVP, Technical Operations Grant or award +40,000 98,199
2021-02-25 Ramelmeier Rolf Andrew EVP, Technical Operations Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-02-25 McClung David Mark EVP, Chief Business Officer Grant or award +40,000 140,000
2021-02-25 McClung David Mark EVP, Chief Business Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-02-25 LOEB GARY EVP, General Counsel & Sec. Shares withheld for taxes −5,762 $11.19 $64K 44,781
2021-02-25 LOEB GARY EVP, General Counsel & Sec. Grant or award +44,000 88,781
2021-02-25 LOEB GARY EVP, General Counsel & Sec. Grant or award · Stock Option (Right to Buy) +88,000 88,000
2021-02-25 Macrae Sandy President and CEO Shares withheld for taxes −35,311 $11.19 $395K 208,691

Page 16 of 17 · 338 trades